InsiderSignal.AI

InsiderSignal.ai

HIMS - Hims & Hers Health, Inc.

Insider Sale by Okupe Oluyemi (CFO)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

3 days ago, Okupe Oluyemi, serving as CFO at Hims & Hers Health, Inc. (HIMS), sold 3,975 shares at $19.98 per share, for a total transaction value of $79,409.00. Following this transaction, Okupe Oluyemi now holds 326,642 shares of HIMS.

This sale represents a 1.00% decrease in Okupe Oluyemi's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, April 6, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, April 7, 2026, 1 day after the trade was made.

Hims & Hers Health, Inc. operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Okupe Oluyemi

CFO

Oluyemi Okupe is the Chief Financial Officer (CFO) of Hims & Hers Health, Inc. (NYSE: HIMS), a position he has held since January 2022.[[1]](https://www.marketscreener.com/insider/OLUYEMI-OKUPE-A3FGC6/)[[3]](https://investors.hims.com/governance/board-of-directors/person-details/default.aspx?ItemId=4a05233a-a95e-41e5-8c9a-c82b1b7fad91) He brings extensive experience in financial leadership at high-growth B2C companies, including roles as CFO at Hipcamp, Inc. (2021-2022), Divisional CFO at Uber Technologies, Inc. (2019-2021) overseeing UberEats and global mobility services across 60 countries, and CFO of the PayPal Division at Braintree Payment Solutions LLC (2016-2019).[[1]](https://www.marketscreener.com/insider/OLUYEMI-OKUPE-A3FGC6/)[[3]](https://investors.hims.com/governance/board-of-directors/person-details/default.aspx?ItemId=4a05233a-a95e-41e5-8c9a-c82b1b7fad91) Okupe holds an undergraduate degree from the University of California, Davis, and a Master of Business Administration from Stanford Graduate School of Business.[[1]](https://www.marketscreener.com/insider/OLUYEMI-OKUPE-A3FGC6/) As CFO, Okupe owns approximately 94,333 to 133,797 shares of HIMS stock, valued at over $3-6 million as of mid-2025, and has engaged in active insider trading, including 29 sells and 1 buy over the past five years, with recent sales such as 23,090 shares on December 22 (at $35.72, totaling ~$825,000) and others in 2025 under trading plans.[[2]](https://www.gurufocus.com/insider/177816/oluyemi-okupe)[[4]](https://es.tradingview.com/news/tradingview:c14963e72bbe9:0-hims-hers-health-cfo-sells-shares-under-trading-plan/)[[5]](https://www.marketbeat.com/instant-alerts/oluyemi-okupe-sells-23090-shares-of-hims-hers-health-nysehims-stock-2025-12-23/) In 2023, his total compensation at Hims & Hers was approximately $7.43 million, including salary, stock awards, and incentives.[[2]](https://www.gurufocus.com/insider/177816/oluyemi-okupe)

View full insider profile →

Trade Price

$19.98

Quantity

3,975

Total Value

$79,409.00

Shares Owned

326,642

Trade Date

Monday, April 6, 2026

3 days ago

SEC Filing Date

Tuesday, April 7, 2026

Filed 1 day after trade

HEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC

About Hims & Hers Health, Inc.

Company Overview

No company information available
View news mentioning HIMS

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/5446751

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime